Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
17. Dezember 2024 08:30 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
13. Dezember 2024 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO
12. Dezember 2024 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Reports Third Quarter 2024 Financial Results
11. November 2024 16:02 ET
|
Assertio Holdings, Inc.
Third Quarter Total Net Product Sales of $28.7 Million Rolvedon Net Product Sales of $15.0 Million Cash and Short-Term Investments of $88.6 Million LAKE FOREST, Ill., Nov. 11, 2024 ...
Assertio Provides Response to Letter from Short-seller
11. November 2024 07:30 ET
|
Assertio Holdings, Inc.
Claims about Rolvedon and Assertio’s Accounting Practices are False and Baseless Short-seller’s Press Release is Another Improper Attempt to Enrich Himself at Assertio’s Expense Company Considering...
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
11. Oktober 2024 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04. Oktober 2024 16:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Reports Second Quarter 2024 Financial Results
07. August 2024 16:01 ET
|
Assertio Holdings, Inc.
Assertio Reports Second Quarter 2024 Financial Results
Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024
24. Juli 2024 16:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
09. Juli 2024 16:30 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., July 09, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...